LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
BIOA BioAge Labs
- 4.630
- +0.260+5.95%
Close Feb 28 16:00 ET
- 4.640
- +0.010+0.21%
Post 20:01 ET
165.98MMarket Cap-2.23P/E (TTM)
4.660High4.360Low309.08KVolume4.500Open4.370Pre Close1.41MTurnover2.94%Turnover RatioLossP/E (Static)35.85MShares26.62052wk High0.53P/B48.62MFloat Cap3.85052wk Low--Dividend TTM10.50MShs Float26.620Historical High--Div YieldTTM6.86%Amplitude3.850Historical Low4.576Avg Price1Lot Size
BioAge Labs News
Bioage Labs Initiated at Market Perform by William Blair
Bioage Labs Analyst Ratings
William Blair Initiates BioAge Labs(BIOA.US) With Hold Rating, Announces Target Price $10
Citi Downgrades BioAge Labs(BIOA.US) to Hold Rating, Cuts Target Price to $7
Morgan Stanley Downgrades BioAge Labs(BIOA.US) to Sell Rating, Cuts Target Price to $5
BioAge Labs Faces Sell Rating Amid Safety Concerns and Uncertain Prospects
BioAge Labs: Strategic Shifts and Developmental Progress Support Hold Rating Amidst Inherent Risks
Morgan Stanley Downgrades BioAge Labs to Underweight From Overweight, Slashes Price Target to $5 From $40
Citigroup Downgrades BioAge Labs to Neutral From Buy, Adjusts Price Target to $7 From $45
Morgan Stanley Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $40
Bioage Labs Analyst Ratings
Jefferies Downgrades Bioage Labs to Hold, Lowers Price Target to $7
Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA), Acadia Healthcare (ACHC) and Bicara Therapeutics Inc. (BCAX)
Morgan Stanley Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $40
Morgan Stanley Keeps Their Buy Rating on BioAge Labs, Inc. (BIOA)
Citi Maintains BioAge Labs(BIOA.US) With Buy Rating, Maintains Target Price $45
Citi Initiates BioAge Labs(BIOA.US) With Buy Rating, Announces Target Price $45
Bioage Labs Analyst Ratings
Jefferies Initiates BioAge Labs(BIOA.US) With Buy Rating, Announces Target Price $42
Morgan Stanley Initiates BioAge Labs(BIOA.US) With Buy Rating, Announces Target Price $40
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025